When the endothelium cannot say 'NO' anymore. ADMA, an endogenous inhibitor of NO synthase, promotes cardiovascular disease
- PMID: 14585247
- DOI: 10.1016/j.ehj.2003.08.010
When the endothelium cannot say 'NO' anymore. ADMA, an endogenous inhibitor of NO synthase, promotes cardiovascular disease
Comment on
-
Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention.Eur Heart J. 2003 Nov;24(21):1912-9. doi: 10.1016/j.ehj.2003.08.013. Eur Heart J. 2003. PMID: 14585249
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
